Search research articles
Contact Us
Filters
Showing results (81-90 of 170) with videos related to
Page
of 17
Sort By:
Cancer Biology & Therapy
|
April 30, 2008
Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil. Is it time to move forward?
Shayna L Showalter, Timothy N Showalter, Agnes Witkiewicz, et al.
Gastroenterology
|
June 10, 2006
Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options
Eike Gallmeier, Eric S Calhoun, Carlo Rago, et al.
Oncotarget
|
November 27, 2016
Quantification and expert evaluation of evidence for chemopredictive biomarkers to personalize cancer treatment
Shruti Rao, Robert A Beckman, Shahla Riazi, et al.
Cancer Biology & Therapy
|
May 1, 2010
Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers
Agnieszka K Witkiewicz, Abhijit Dasgupta, Sara Sammons, et al.
Cancer Research Communications
|
November 24, 2025
MicroCT Enables Simultaneous Longitudinal Tracking of Murine Pancreatic Cancer Progression and Cachexia
Katherine R Pelz, Philip Jimenez, Colin J Daniel, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
August 10, 2018
RNA binding protein HuR regulates extracellular matrix gene expression and pH homeostasis independent of controlling HIF-1α signaling in nucleus pulposus cells
Hehai Pan, Adam Strickland, Vedavathi Madhu, et al.
Molecular Cancer Research : MCR
|
February 17, 2021
AraC-FdUMP[10] Is a Next-Generation Fluoropyrimidine with Potent Antitumor Activity in PDAC and Synergy with <i>PARG</i> Inhibition
Alex O Haber, Aditi Jain, Chinnadurai Mani, et al.
Scientific Reports
|
September 13, 2016
WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner
Shruti Lal, Mahsa Zarei, Saswati N Chand, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2025
MicroCT enables simultaneous longitudinal tracking of murine pancreatic cancer progression and cachexia
Katherine R Pelz, Philip Jimenez, Colin J Daniel, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
November 5, 2014
PARP inhibitors for chemoprevention--letter
Saswati N Chand, Fernando F Blanco, Masaya Jimbo, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 170) with videos related to
Sort By:
Page
of 17
Cancer Biology & Therapy
|
April 30, 2008
Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil. Is it time to move forward?
Shayna L Showalter, Timothy N Showalter, Agnes Witkiewicz, et al.
Gastroenterology
|
June 10, 2006
Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options
Eike Gallmeier, Eric S Calhoun, Carlo Rago, et al.
Oncotarget
|
November 27, 2016
Quantification and expert evaluation of evidence for chemopredictive biomarkers to personalize cancer treatment
Shruti Rao, Robert A Beckman, Shahla Riazi, et al.
Cancer Biology & Therapy
|
May 1, 2010
Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers
Agnieszka K Witkiewicz, Abhijit Dasgupta, Sara Sammons, et al.
Cancer Research Communications
|
November 24, 2025
MicroCT Enables Simultaneous Longitudinal Tracking of Murine Pancreatic Cancer Progression and Cachexia
Katherine R Pelz, Philip Jimenez, Colin J Daniel, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
August 10, 2018
RNA binding protein HuR regulates extracellular matrix gene expression and pH homeostasis independent of controlling HIF-1α signaling in nucleus pulposus cells
Hehai Pan, Adam Strickland, Vedavathi Madhu, et al.
Molecular Cancer Research : MCR
|
February 17, 2021
AraC-FdUMP[10] Is a Next-Generation Fluoropyrimidine with Potent Antitumor Activity in PDAC and Synergy with <i>PARG</i> Inhibition
Alex O Haber, Aditi Jain, Chinnadurai Mani, et al.
Scientific Reports
|
September 13, 2016
WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner
Shruti Lal, Mahsa Zarei, Saswati N Chand, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2025
MicroCT enables simultaneous longitudinal tracking of murine pancreatic cancer progression and cachexia
Katherine R Pelz, Philip Jimenez, Colin J Daniel, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
November 5, 2014
PARP inhibitors for chemoprevention--letter
Saswati N Chand, Fernando F Blanco, Masaya Jimbo, et al.
Page
of 17